Plasma Fractionation Market - Top Companies and Manufacturers

Companies Dominating the Plasma Fractionation Landscape

CSL Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Grifols, S.A.
Takeda Pharmaceutical Company Limited
Kedrion S.p.A
Octapharma AG
Bio Products Laboratory Ltd.
Biotest AG
LFB Group
Japan Blood Products Organization
Intas Pharmaceuticals Ltd.

Browse Key Market Insights with Data Illustration:

Plasma Fractionation Market Size & Share, Growth Forecasts 2033

In the News

Grifols, S.A., a global healthcare company and one of the world's leading producers of plasma-derived medicines, announced the acquisition of its first donation center in Canada as part of the company's commitment to increasing access to lifesaving plasma medications in the country.
The Czech health authority SUKL has granted Biotest AG the operating license for the 12th Cara Plasma plasmapheresis center in the Czech Republic.

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are increase In number of chronic diseases, growing geriatric population, increased investment by major players, and others.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 â€“ 2033.

High cost related to plasma therapy, increasing use of recombinant alternatives, and restricted medical reimbursement policies are some of the major factors expected to hinder the growth of the market.

The market in Europe is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are CSL Limited, Grifols, S.A., Takeda Pharmaceutical Company Limited, Kedrion S.p.A and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The neurology segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Plasma Fractionation Market - Top Companies and Manufacturers

Companies Dominating the Plasma Fractionation Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the plasma fractionation market?

What would be the CAGR of plasma fractionation market over the forecast period?

What are the challenges affecting the plasma fractionation market growth?

Which region will provide more business opportunities for growth of plasma fractionation market in future?

Who are the major players dominating the plasma fractionation market?

How are the company profiles selected?

What are the segments in the plasma fractionation market?

Which segment captures the largest market size in application in the plasma fractionation market?